Plasmacure

The AI engine Fit Assessment

Beta

The company will be attending the 2024 Health Tech Forward Event

Blurb

Plasmacure is a medical device to cure advanced wounds.

HQ Location

Eindhoven (Netherlands)

Founded

2014

Employees

1 - 10

Total funding raised

$4.08M

Funding Status

Convertible Note, $1.30M, July 5, 2023

Millions of people live with wounds that won’t heal.



These wounds limit mobility, cause pain, and take away independence. Current treatments are often slow, expensive, and frustrating — for patients, caregivers, and healthcare systems alike.



At Plasmacure, we’re changing that.



Our patented cold plasma system, PLASOMA, is the first solution proven to close chronic wounds faster, safer, and more effectively.



Clinically validated

In a randomized controlled trial, PLASOMA was shown to be 2.5x more effective than traditional wound care.



Cuts costs, boosts efficiency

Treatment with PLASOMA can reduce healthcare costs by more than 40% and free up clinicians’ time by more than 50%.



Fast and easy

Each session takes just two minutes and fits easily into existing care routines.



Safe in clinic and at home

PLASOMA is currently the only cold plasma wound care solution proven safe and effective for both in-clinic and home use, validated through a peer-reviewed RCT.



With a CE-marked Class IIb medical device already on the market, we are expanding across Europe and preparing entry into the United States and China.